A federal appeals court today upheld an Arkansas law that prohibits drug manufacturer 340B contract pharmacy restrictions in the state. [...] …
Breaking
After more than six months of long meetings with stakeholders, a bipartisan group of six senators released draft legislation Friday [...] …
Please Login or Become a Paid Subscriber to View this Content
A federal district judge in South Carolina late today struck down the 340B program’s patient definition, as federal regulators described [...] …
Please Login or Become a Paid Subscriber to View this Content
Breaking News
CMS Proposes $9 Billion in Lump Sum Payments to Reimburse Hospitals for Past 340B Part B Drug Payment Cuts
The U.S. Centers for Medicare & Medicaid Services plans to provide lump sum Medicare Part B drug payments to 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
Breaking News
House E&C Committee Passes Two Bills That Would Create 340B Entity Reporting Requirements
In a significant development, a GOP-led U.S. House health subcommittee this afternoon voted 16 to 12 along party lines to pass and send to the full committee legislation to impose significant new reporting requirements on 340B disproportionate share hospitals.
…Breaking News
HRSA and Prime Vendor Yank FAQs About 340B Use in Hospital Child Sites, and GAO Issues a New 340B Study
The U.S. Health Resources and Services Administration midday yesterday and the 340B prime vendor Apexus this morning, in connection with the end of the COVID-19 public health emergency late last night, withdrew mostly identical 340B program FAQs about use
…
UPDATE Friday, March 31, 2023, 6:45 p.m. EDT—Story updated with comment from the National Association of Community Health Centers.
Drug manufacturer GlaxoSmithKline this afternoon announced a major expansion of its conditions on 340B pricing in
…Breaking News
Major Drug Industry and Health Center Groups Unite to Reform 340B for Patients and “True” Safety-Net Providers
Pharmaceutical Research and Manufacturers of America, the National Association of Community Health Centers, and the National Hispanic Medical Association this morning jointly issued a 10-point plan and created a nonprofit group to ensure that the 340B program “benefits patients
…Breaking News
EMD Serono Is the Second Drug Maker Today to Impose Conditions on 340B Contract Pharmacy, and the 21st Overall
EMD Serono today became the 21st pharmaceutical manufacturer to impose conditions on 340B pricing involving drug shipments to contract pharmacies.
Bayer announced conditions on 340B sales involving contract pharmacies earlier today. The companies’ announcements came two
…